* Medifast Inc MED.N MED is expected to show a rise in
quarterly revenue when it reports results on August 4.
* The Owings Mills, Maryland-based company is expected to report
a 63.4% increase in revenue to $359.513 million from $220
million a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Medifast Inc is for
earnings of $3.32 per share. For the same quarter last year, the
company reported earnings of $1.96 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Medifast Inc is
$350, about 20.2% above its last closing price of $279.44.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 2.74 2.73 3.46 Beat 26.9
Dec. 31 2020 2.37 2.38 2.36 Missed -0.8
Sep. 30 2020 2.54 2.46 2.91 Beat 18.5
Jun. 30 2020 1.84 1.83 1.96 Beat 7
Mar. 1.31 1.33 1.93 Beat 45.4
31 2020
Dec. 31 2019 1.08 1.07 1.66 Beat 54.5
Sep. 30 2019 1.34 1.34 1.32 Missed -1.2
Jun. 30 2019 1.72 1.72 1.75 Beat 1.6
This summary was machine generated August 3 at 02:01 GMT. All
figures in US dollars unless otherwise stated